IL132903A0 - N-triazolyl-2-indolecarboxamides and their their use as cck-a agonists - Google Patents
N-triazolyl-2-indolecarboxamides and their their use as cck-a agonistsInfo
- Publication number
- IL132903A0 IL132903A0 IL13290398A IL13290398A IL132903A0 IL 132903 A0 IL132903 A0 IL 132903A0 IL 13290398 A IL13290398 A IL 13290398A IL 13290398 A IL13290398 A IL 13290398A IL 132903 A0 IL132903 A0 IL 132903A0
- Authority
- IL
- Israel
- Prior art keywords
- indolecarboxamides
- cck
- triazolyl
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9705850A FR2763337B1 (fr) | 1997-05-13 | 1997-05-13 | Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant |
PCT/FR1998/000905 WO1998051686A1 (fr) | 1997-05-13 | 1998-05-06 | N-triazolyl-2-indolecarboxamides et leur utilisation comme agonistes de cck-a |
Publications (1)
Publication Number | Publication Date |
---|---|
IL132903A0 true IL132903A0 (en) | 2001-03-19 |
Family
ID=9506830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13290398A IL132903A0 (en) | 1997-05-13 | 1998-05-06 | N-triazolyl-2-indolecarboxamides and their their use as cck-a agonists |
Country Status (35)
Country | Link |
---|---|
EP (1) | EP0984960B1 (de) |
JP (1) | JP2001524980A (de) |
KR (1) | KR20010012541A (de) |
CN (1) | CN1263528A (de) |
AR (1) | AR011729A1 (de) |
AT (1) | ATE232207T1 (de) |
AU (1) | AU725530B2 (de) |
BR (1) | BR9811465A (de) |
CA (1) | CA2289573A1 (de) |
CO (1) | CO4940485A1 (de) |
CZ (1) | CZ289484B6 (de) |
DE (1) | DE69811223T2 (de) |
DK (1) | DK0984960T3 (de) |
DZ (1) | DZ2486A1 (de) |
EE (1) | EE9900524A (de) |
ES (1) | ES2190081T3 (de) |
FR (1) | FR2763337B1 (de) |
GT (1) | GT199800068A (de) |
HR (1) | HRP980258B1 (de) |
HU (1) | HUP0002763A3 (de) |
ID (1) | ID22911A (de) |
IL (1) | IL132903A0 (de) |
IS (1) | IS5235A (de) |
NO (1) | NO995513L (de) |
NZ (1) | NZ500637A (de) |
PL (1) | PL336772A1 (de) |
RU (1) | RU2175323C2 (de) |
SI (1) | SI0984960T1 (de) |
SK (1) | SK154299A3 (de) |
TR (1) | TR199902795T2 (de) |
TW (1) | TW396155B (de) |
UY (1) | UY24997A1 (de) |
WO (1) | WO1998051686A1 (de) |
YU (1) | YU57999A (de) |
ZA (1) | ZA983997B (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2802530B1 (fr) * | 1999-12-17 | 2002-02-22 | Sanofi Synthelabo | Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant |
FR2815963B1 (fr) * | 2000-10-26 | 2003-02-28 | Sanofi Synthelabo | Nouveaux derives du triazole et les compositions pharmaceutiques les contenant |
US20040019091A1 (en) * | 2000-10-26 | 2004-01-29 | Eric Bignon | Triazole derivatives and pharmaceutical compositions comprising them |
HUP0004741A2 (hu) * | 2000-11-28 | 2002-12-28 | Sanofi-Synthelabo | Kémiai eljárás tiazolszármazékok előállítására és új intermedier |
ES2256560T3 (es) * | 2001-10-12 | 2006-07-16 | Bayer Pharmaceuticals Corporation | Heterociclos de 5 mienbros que contienen nitrogeno sustituidos con felino para el tratamiento de la obesidad. |
EP1314733A1 (de) * | 2001-11-22 | 2003-05-28 | Aventis Pharma Deutschland GmbH | Indol-2-carbonsäureamide als Faktor-Xa-Hemmer |
EP1479677A1 (de) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Neue Indolderivate als Faktor Xa-Inhibitoren |
EP1532980A1 (de) * | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-Heteroaryl Indol-Carboxamide und deren analoga zur Vewendung als glucokinase Aktivatoren zur Behandlung von Diabetes |
GB0403038D0 (en) * | 2004-02-11 | 2004-03-17 | Novartis Ag | Organic compounds |
ATE528006T1 (de) * | 2007-01-26 | 2011-10-15 | Merck Sharp & Dohme | Substituierte aminopyrimidine als cholecystokinin-1-rezeptormodulatoren |
CA2731097A1 (en) * | 2008-07-15 | 2010-01-21 | Novartis Ag | Organic compounds |
CN102414207B (zh) * | 2009-06-09 | 2015-09-30 | 埃科特莱茵药品有限公司 | 氟化氨基三唑衍生物 |
EP2490656B1 (de) * | 2009-10-22 | 2017-01-18 | Henkel AG & Co. KGaA | Mittel zur behandlung keratinhaltiger fasern, enthaltend eine nichtionische, mittels propylenoxid modifizierte stärke und ein anionisches polymer |
CN106928147A (zh) * | 2017-03-14 | 2017-07-07 | 华东师范大学 | 三环二萜类似物及其制备方法、及其在制备抗前列腺癌药物中的应用 |
CN107271623A (zh) * | 2017-07-27 | 2017-10-20 | 青岛啤酒股份有限公司 | 基于人体饱腹感的啤酒可饮性评价方法 |
BR112022006546A2 (pt) | 2019-10-07 | 2022-08-30 | Kallyope Inc | Agonistas de gpr119 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2701708B1 (fr) * | 1993-02-19 | 1995-05-19 | Sanofi Elf | Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament. |
FR2703995B1 (fr) * | 1993-04-16 | 1995-07-21 | Sanofi Elf | 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant. |
-
1997
- 1997-05-13 FR FR9705850A patent/FR2763337B1/fr not_active Expired - Fee Related
-
1998
- 1998-05-06 ID IDW991374A patent/ID22911A/id unknown
- 1998-05-06 AT AT98924383T patent/ATE232207T1/de not_active IP Right Cessation
- 1998-05-06 CA CA002289573A patent/CA2289573A1/fr not_active Abandoned
- 1998-05-06 TR TR1999/02795T patent/TR199902795T2/xx unknown
- 1998-05-06 YU YU57999A patent/YU57999A/sh unknown
- 1998-05-06 EP EP98924383A patent/EP0984960B1/de not_active Expired - Lifetime
- 1998-05-06 CZ CZ19994006A patent/CZ289484B6/cs not_active IP Right Cessation
- 1998-05-06 WO PCT/FR1998/000905 patent/WO1998051686A1/fr not_active Application Discontinuation
- 1998-05-06 HU HU0002763A patent/HUP0002763A3/hu unknown
- 1998-05-06 IL IL13290398A patent/IL132903A0/xx unknown
- 1998-05-06 DE DE69811223T patent/DE69811223T2/de not_active Expired - Fee Related
- 1998-05-06 RU RU99125773/04A patent/RU2175323C2/ru not_active IP Right Cessation
- 1998-05-06 SI SI9830372T patent/SI0984960T1/xx unknown
- 1998-05-06 ES ES98924383T patent/ES2190081T3/es not_active Expired - Lifetime
- 1998-05-06 BR BR9811465-4A patent/BR9811465A/pt not_active IP Right Cessation
- 1998-05-06 DZ DZ980096A patent/DZ2486A1/xx active
- 1998-05-06 CN CN98807175A patent/CN1263528A/zh active Pending
- 1998-05-06 SK SK1542-99A patent/SK154299A3/sk unknown
- 1998-05-06 KR KR1019997010496A patent/KR20010012541A/ko not_active Application Discontinuation
- 1998-05-06 AU AU76599/98A patent/AU725530B2/en not_active Ceased
- 1998-05-06 EE EEP199900524A patent/EE9900524A/xx unknown
- 1998-05-06 NZ NZ500637A patent/NZ500637A/xx unknown
- 1998-05-06 JP JP54885398A patent/JP2001524980A/ja not_active Ceased
- 1998-05-06 DK DK98924383T patent/DK0984960T3/da active
- 1998-05-06 PL PL98336772A patent/PL336772A1/xx unknown
- 1998-05-06 CO CO98024703A patent/CO4940485A1/es unknown
- 1998-05-11 AR ARP980102152A patent/AR011729A1/es active IP Right Grant
- 1998-05-12 UY UY24997A patent/UY24997A1/es not_active IP Right Cessation
- 1998-05-12 ZA ZA9803997A patent/ZA983997B/xx unknown
- 1998-05-12 TW TW087107326A patent/TW396155B/zh active
- 1998-05-13 HR HR980258A patent/HRP980258B1/xx not_active IP Right Cessation
- 1998-05-20 GT GT199800068A patent/GT199800068A/es unknown
-
1999
- 1999-10-29 IS IS5235A patent/IS5235A/is unknown
- 1999-11-11 NO NO995513A patent/NO995513L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9711141B (en) | Novel ketobenzamides and their use | |
EP1032377A4 (de) | Substituierte 2-aminoacetamide und anwendung davon | |
GB9813271D0 (en) | Composition and use | |
ZA200101933B (en) | Novel composition and use | |
ZA985096B (en) | Composition compound and use | |
HK1033653A1 (en) | Synergistic composition and use thereof | |
GB9717598D0 (en) | Novel composition and use | |
IL132903A0 (en) | N-triazolyl-2-indolecarboxamides and their their use as cck-a agonists | |
GB9702354D0 (en) | Compounds and their use | |
GB9811168D0 (en) | Direct hair-colouring compositions and the use thereof | |
GB2367749B (en) | Depilatory compositions and their use | |
HUP0104723A3 (en) | New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use | |
IL123535A0 (en) | Benzoxazindione derivatives and their use | |
GB9622905D0 (en) | Dispersing agents and their use | |
GB9718636D0 (en) | Novel composition and use | |
EP0998578A4 (de) | Sel-10 und dessen verwendungen | |
PL341293A1 (en) | Beta-lypothropin and application thereof | |
GB9722392D0 (en) | Composition and use | |
GB9413076D0 (en) | Composition and use | |
GB9805172D0 (en) | Composition and use | |
GB9722390D0 (en) | Composition and use | |
GB9712961D0 (en) | Composition and use | |
GB9716805D0 (en) | Novel composition and use | |
GB9719203D0 (en) | Novel composition and use | |
GB9715323D0 (en) | Piperidinecarboxamides and their use |